Tevra Brands LLC v. Bayer HealthCare LLC

Good Law
United States District Court, Northern District of CaliforniaJune 23, 20205:19-cv-04312California3,213 words

Opinion

trial_court Opinion

1 2 3 UNITED STATES DISTRICT COURT 4 NORTHERN DISTRICT OF CALIFORNIA 5 SAN JOSE DIVISION 6 7 TEVRA BRANDS LLC, Case No. 19-cv-04312-BLF

8 Plaintiff, ORDER DENYING PLAINTIFF'S 9 v. MOTION FOR ALTERNATIVE

SERVICE WITHOUT PREJUDICE

10 BAYER HEALTHCARE LLC, et al., [Re: ECF 116] 11 Defendants.

12 13 Tevra Brands, LLC (“Tevra”) brings this antitrust suit against Bayer Healthcare LLC, Bayer 14 Animal Health GmbH, and Bayer AG related to the distribution of “squeeze on” Imidacloprid 15 topical flea and tick treatments for pets. See Compl., ECF 1. Before the Court is Plaintiff Tevra’s 16 Motion for Alternative Service. See Mot. For Alt. Service (“Mot.”), ECF 116. Tevra seeks an order 17 from the Court authorizing Tevra to serve Bayer Animal Health GmbH and Bayer AG (collectively, 18 “German Defendants”) through their U.S.-based lead counsel, Daniel Asimow, by email. Id. On 19 May 29, 2019 Bayer Healthcare LLC filed an Opposition. See Opp’n, ECF 117. On June 5, 2019, 20 Tevra filed a Reply. See Reply, ECF…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.